FDA advisors on Wednesday will deliberate on whether shunt therapy still has a narrow path forward in heart failure after a disappointing pivotal trial. In its premarket approval application for the ...

Congenital heart defects (CHDs) are among the top eight causes of infant mortality worldwide. Annually, CHDs affect around 40,000 infants in the United States, with approximately one in four having a ...

For babies born with a certain heart defect, implantation of a "shunt" is essential to their survival. A new type of shunt can be expanded using light after it's been implanted, potentially ...

DENVER, Aug. 19, 2024 — Children born with defects that impair the heart’s lower chambers undergo a series of invasive surgeries early in life. The first surgery includes implantation of a plastic ...